Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
5 Fast Indian Breakfast Recipes In 15 Minutes
Do you usually skip breakfast not because you aren't hungry, but because of lack of time? We hear you. That's why we...
Low Carb Food plan Could Assist Individuals With Sort 2 Diabetes Go Into Remission
Share on PinterestA new study looked at how a low-carb diet can help people with type 2 diabetes in the short term. People...